IMMURON LIMITED - Announcements

0.00%

6.8¢

Market Cap $18.23M

Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Announcements

Filter Results

All Price Sensitive Only

IMC	FY25 Results Presentation	PRICE SENSITIVE	29/08/25	1.89MB	Share
IMC	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	29/08/25	143.05KB	Share
IMC	Immuron partners with InvestorHub		26/08/25	437.29KB	Share
IMC	Notification regarding unquoted securities - IMC		15/08/25	16.23KB	Share
IMC	Emerging Growth Conference Presentation		13/08/25	278.24KB	Share
IMC	Presentation to Coffee Microcaps Conference		25/07/25	2.47MB	Share
IMC	Change in substantial holding		23/07/25	462.24KB	Share
IMC	Notification of cessation of securities - IMC		22/07/25	12.76KB	Share
IMC	Notice under section 708A		21/07/25	179.14KB	Share
IMC	Application for quotation of securities - IMC		21/07/25	14.16KB	Share
IMC	Proposed issue of securities - IMC		18/07/25	15.81KB	Share
IMC	Notice under section 708A		18/07/25	178.8KB	Share
IMC	Application for quotation of securities - IMC		18/07/25	16.05KB	Share
IMC	Proposed issue of securities - IMC		17/07/25	15.22KB	Share
IMC	Notice under section 708A		17/07/25	178.79KB	Share
IMC	Application for quotation of securities - IMC		17/07/25	15.63KB	Share
IMC	FY25 global sales exceed projection, up 49% on prior year	PRICE SENSITIVE	17/07/25	333.58KB	Share
IMC	Proposed issue of securities - IMC		16/07/25	15.04KB	Share
IMC	Change in substantial holding		01/07/25	385.63KB	Share
IMC	Notice under section 708A		04/06/25	208.38KB	Share
IMC	Application for quotation of securities - IMC		04/06/25	15.48KB	Share
IMC	Proposed issue of securities - IMC		03/06/25	14.72KB	Share
IMC	Letter to Shareholders		30/05/25	335.84KB	Share
IMC	Notice under section 708A		30/05/25	208.53KB	Share
IMC	Application for quotation of securities - IMC		30/05/25	15.48KB	Share
IMC	Proposed issue of securities - IMC		29/05/25	14.72KB	Share
IMC	Notice under section 708A		11/04/25	191.76KB	Share
IMC	Notification of cessation of securities - IMC		11/04/25	12.74KB	Share
IMC	Application for quotation of securities - IMC		11/04/25	15.68KB	Share
IMC	Immuron Travelan highest sales in history	PRICE SENSITIVE	10/04/25	273.79KB	Share
IMC	Immuron CEO presentation to Coffee Microcaps Conference		07/03/25	2.55MB	Share
IMC	IMC and Calmino to treat Irritable Bowel Syndrome (IBS)	PRICE SENSITIVE	05/03/25	430.21KB	Share
IMC	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/25	2.82MB	Share
IMC	Immuron CEO presentation to Emerging Growth Conference		19/02/25	1.52MB	Share
IMC	Notice under section 708A		17/01/25	180.14KB	Share
IMC	Application for quotation of securities - IMC		17/01/25	15.56KB	Share
IMC	Immuron Travelan continued strong sales growth	PRICE SENSITIVE	17/01/25	274.47KB	Share
IMC	Proposed issue of securities - IMC		15/01/25	15.13KB	Share
IMC	Immuron Announces Monash AMR Research Collaboration		15/01/25	345.78KB	Share
IMC	Immuron Announces Travelan Clinical Trial Update	PRICE SENSITIVE	14/01/25	328.52KB	Share
IMC	Notice under section 708A		10/01/25	192.46KB	Share
IMC	Application for quotation of securities - IMC		10/01/25	15.56KB	Share
IMC	Proposed issue of securities - IMC		08/01/25	15.06KB	Share
IMC	Change of Director's Interest Notice (RS)		10/12/24	118.82KB	Share
IMC	Change of Director's Interest Notice (DP)		10/12/24	118.35KB	Share
IMC	Change of Director's Interest Notice (JJ)		10/12/24	121.11KB	Share
IMC	Notification regarding unquoted securities - IMC		10/12/24	16.72KB	Share
IMC	Immuron CEO presentation to Virtual Investor Summit		22/11/24	2.13MB	Share
IMC	Results of Meeting		18/11/24	136.65KB	Share
IMC	2024 AGM Presentation		18/11/24	1.52MB	Share
IMC	Change of Director's Interest Notice (DP RS)		14/11/24	187.18KB	Share
IMC	Notification of cessation of securities - IMC		14/11/24	12.77KB	Share
IMC	Notification regarding unquoted securities - IMC		29/10/24	16.46KB	Share
IMC	Change in substantial holding		23/10/24	483.92KB	Share
IMC	Notice of Annual General Meeting		18/10/24	389.24KB	Share
IMC	IMC CEO to participate in Maxim Healthcare - addendum		16/10/24	3.06MB	Share
IMC	IMC CEO to participate in Maxim Healthcare Conference		16/10/24	1.61MB	Share
IMC	Immuron Travelan continued strong sales growth	PRICE SENSITIVE	15/10/24	287.9KB	Share
IMC	Notice under section 708A		08/10/24	186.78KB	Share
IMC	Application for quotation of securities - IMC		08/10/24	16.12KB	Share
IMC	NMRC Reports Results for Campylobacter Clinical Study	PRICE SENSITIVE	04/10/24	279.74KB	Share
IMC	Trading Halt	PRICE SENSITIVE	03/10/24	197.27KB	Share
IMC	Appendix 4G		30/09/24	260.87KB	Share
IMC	Corporate Governance Statement		30/09/24	201.13KB	Share
IMC	Annual Report		30/09/24	8.98MB	Share
IMC	Immuron CEO presentation to Emerging Growth Conference		26/09/24	2.9MB	Share
IMC	Immuron Plans Phase 2 Trial for IMM-529 following FDA review	PRICE SENSITIVE	05/09/24	377.73KB	Share
IMC	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/24	1.76MB	Share
IMC	Immuron CEO presentation to Peak Biotech Showcase		21/08/24	2.71MB	Share
IMC	New US DoD Research Award to develop enhanced Travelan		16/08/24	312.59KB	Share
IMC	Immuron CEO presentation to MarketOpen Direct Connect		08/08/24	2.34MB	Share
IMC	Immuron CEO to host webinar on MarketOpen Direct Connect		07/08/24	228.84KB	Share
IMC	Change in substantial holding		06/08/24	466.25KB	Share
IMC	Immuron CEO to present at TechKnow Invest Roadshow		31/07/24	2.46MB	Share
IMC	Immuron CEO to present at Emerging Growth Conference		18/07/24	2.57MB	Share
IMC	Notification of cessation of securities - IMC		16/07/24	12.77KB	Share
IMC	Immuron Travelan record sales globally, Australia and USA	PRICE SENSITIVE	15/07/24	268.76KB	Share
IMC	Immuron CEO Steven Lydeamore presentation to Sharewise		09/07/24	4.34MB	Share
IMC	Immuron CEO Steven Lydeamore to present at Sharewise		04/07/24	272.38KB	Share
IMC	Immuron lodges Form F-3 and ATM Prospectus with U.S. SEC		03/07/24	986.77KB	Share
IMC	IMM-529 pre-IND FDA filing	PRICE SENSITIVE	02/07/24	367.2KB	Share
IMC	Initial Director's Interest Notice JJ		05/06/24	168.43KB	Share
IMC	Final Director's Interest Notice RA		05/06/24	176.44KB	Share
IMC	Board Changes		31/05/24	215.04KB	Share
IMC	Immuron CEO Steven Lydeamore to present at Peak Sky High		31/05/24	2.55MB	Share
IMC	Notification of cessation of securities - IMC		24/05/24	12.8KB	Share
IMC	Final Director's Interest Notice (SA)		03/05/24	179.96KB	Share
IMC	Board Change		03/05/24	261.18KB	Share
IMC	Change in substantial holding		30/04/24	643.75KB	Share
IMC	Immuron CEO Steven Lydeamore to present at The Watchlist		23/04/24	1.83MB	Share
IMC	Immuron to host Live Virtual Event		15/04/24	296.16KB	Share
IMC	Immuron Travelan sales continued strong growth	PRICE SENSITIVE	10/04/24	315.78KB	Share
IMC	Change in substantial holding		22/03/24	1.51MB	Share
IMC	Notice under section 708A		14/03/24	179.38KB	Share
IMC	Change of Director's Interest Notice (DP)		14/03/24	168.99KB	Share
IMC	Application for quotation of securities - IMC		14/03/24	16.05KB	Share
IMC	Immuron CEO, Steven Lydeamore to present at Coffee Microcaps		14/03/24	1.29MB	Share
IMC	Change in substantial holding		14/03/24	1.49MB	Share
IMC	Travelan to progress to Phase 3 Clinical Trials in the US	PRICE SENSITIVE	07/03/24	408.71KB	Share
IMC	Trading Halt	PRICE SENSITIVE	05/03/24	221.96KB	Share

IMC FY25 Results Presentation
29/08/25	PRICE SENSITIVE	1.89MB	Share
IMC Appendix 4E Preliminary Final Report
29/08/25	PRICE SENSITIVE	143.05KB	Share
IMC Immuron partners with InvestorHub
26/08/25		437.29KB	Share
IMC Notification regarding unquoted securities - IMC
15/08/25		16.23KB	Share
IMC Emerging Growth Conference Presentation
13/08/25		278.24KB	Share
IMC Presentation to Coffee Microcaps Conference
25/07/25		2.47MB	Share
IMC Change in substantial holding
23/07/25		462.24KB	Share
IMC Notification of cessation of securities - IMC
22/07/25		12.76KB	Share
IMC Notice under section 708A
21/07/25		179.14KB	Share
IMC Application for quotation of securities - IMC
21/07/25		14.16KB	Share
IMC Proposed issue of securities - IMC
18/07/25		15.81KB	Share
IMC Notice under section 708A
18/07/25		178.8KB	Share
IMC Application for quotation of securities - IMC
18/07/25		16.05KB	Share
IMC Proposed issue of securities - IMC
17/07/25		15.22KB	Share
IMC Notice under section 708A
17/07/25		178.79KB	Share
IMC Application for quotation of securities - IMC
17/07/25		15.63KB	Share
IMC FY25 global sales exceed projection, up 49% on prior year
17/07/25	PRICE SENSITIVE	333.58KB	Share
IMC Proposed issue of securities - IMC
16/07/25		15.04KB	Share
IMC Change in substantial holding
01/07/25		385.63KB	Share
IMC Notice under section 708A
04/06/25		208.38KB	Share
IMC Application for quotation of securities - IMC
04/06/25		15.48KB	Share
IMC Proposed issue of securities - IMC
03/06/25		14.72KB	Share
IMC Letter to Shareholders
30/05/25		335.84KB	Share
IMC Notice under section 708A
30/05/25		208.53KB	Share
IMC Application for quotation of securities - IMC
30/05/25		15.48KB	Share
IMC Proposed issue of securities - IMC
29/05/25		14.72KB	Share
IMC Notice under section 708A
11/04/25		191.76KB	Share
IMC Notification of cessation of securities - IMC
11/04/25		12.74KB	Share
IMC Application for quotation of securities - IMC
11/04/25		15.68KB	Share
IMC Immuron Travelan highest sales in history
10/04/25	PRICE SENSITIVE	273.79KB	Share
IMC Immuron CEO presentation to Coffee Microcaps Conference
07/03/25		2.55MB	Share
IMC IMC and Calmino to treat Irritable Bowel Syndrome (IBS)
05/03/25	PRICE SENSITIVE	430.21KB	Share
IMC Appendix 4D and Half Year Report
28/02/25	PRICE SENSITIVE	2.82MB	Share
IMC Immuron CEO presentation to Emerging Growth Conference
19/02/25		1.52MB	Share
IMC Notice under section 708A
17/01/25		180.14KB	Share
IMC Application for quotation of securities - IMC
17/01/25		15.56KB	Share
IMC Immuron Travelan continued strong sales growth
17/01/25	PRICE SENSITIVE	274.47KB	Share
IMC Proposed issue of securities - IMC
15/01/25		15.13KB	Share
IMC Immuron Announces Monash AMR Research Collaboration
15/01/25		345.78KB	Share
IMC Immuron Announces Travelan Clinical Trial Update
14/01/25	PRICE SENSITIVE	328.52KB	Share
IMC Notice under section 708A
10/01/25		192.46KB	Share
IMC Application for quotation of securities - IMC
10/01/25		15.56KB	Share
IMC Proposed issue of securities - IMC
08/01/25		15.06KB	Share
IMC Change of Director's Interest Notice (RS)
10/12/24		118.82KB	Share
IMC Change of Director's Interest Notice (DP)
10/12/24		118.35KB	Share
IMC Change of Director's Interest Notice (JJ)
10/12/24		121.11KB	Share
IMC Notification regarding unquoted securities - IMC
10/12/24		16.72KB	Share
IMC Immuron CEO presentation to Virtual Investor Summit
22/11/24		2.13MB	Share
IMC Results of Meeting
18/11/24		136.65KB	Share
IMC 2024 AGM Presentation
18/11/24		1.52MB	Share
IMC Change of Director's Interest Notice (DP RS)
14/11/24		187.18KB	Share
IMC Notification of cessation of securities - IMC
14/11/24		12.77KB	Share
IMC Notification regarding unquoted securities - IMC
29/10/24		16.46KB	Share
IMC Change in substantial holding
23/10/24		483.92KB	Share
IMC Notice of Annual General Meeting
18/10/24		389.24KB	Share
IMC IMC CEO to participate in Maxim Healthcare - addendum
16/10/24		3.06MB	Share
IMC IMC CEO to participate in Maxim Healthcare Conference
16/10/24		1.61MB	Share
IMC Immuron Travelan continued strong sales growth
15/10/24	PRICE SENSITIVE	287.9KB	Share
IMC Notice under section 708A
08/10/24		186.78KB	Share
IMC Application for quotation of securities - IMC
08/10/24		16.12KB	Share
IMC NMRC Reports Results for Campylobacter Clinical Study
04/10/24	PRICE SENSITIVE	279.74KB	Share
IMC Trading Halt
03/10/24	PRICE SENSITIVE	197.27KB	Share
IMC Appendix 4G
30/09/24		260.87KB	Share
IMC Corporate Governance Statement
30/09/24		201.13KB	Share
IMC Annual Report
30/09/24		8.98MB	Share
IMC Immuron CEO presentation to Emerging Growth Conference
26/09/24		2.9MB	Share
IMC Immuron Plans Phase 2 Trial for IMM-529 following FDA review
05/09/24	PRICE SENSITIVE	377.73KB	Share
IMC Appendix 4E and Preliminary Final Report
30/08/24	PRICE SENSITIVE	1.76MB	Share
IMC Immuron CEO presentation to Peak Biotech Showcase
21/08/24		2.71MB	Share
IMC New US DoD Research Award to develop enhanced Travelan
16/08/24		312.59KB	Share
IMC Immuron CEO presentation to MarketOpen Direct Connect
08/08/24		2.34MB	Share
IMC Immuron CEO to host webinar on MarketOpen Direct Connect
07/08/24		228.84KB	Share
IMC Change in substantial holding
06/08/24		466.25KB	Share
IMC Immuron CEO to present at TechKnow Invest Roadshow
31/07/24		2.46MB	Share
IMC Immuron CEO to present at Emerging Growth Conference
18/07/24		2.57MB	Share
IMC Notification of cessation of securities - IMC
16/07/24		12.77KB	Share
IMC Immuron Travelan record sales globally, Australia and USA
15/07/24	PRICE SENSITIVE	268.76KB	Share
IMC Immuron CEO Steven Lydeamore presentation to Sharewise
09/07/24		4.34MB	Share
IMC Immuron CEO Steven Lydeamore to present at Sharewise
04/07/24		272.38KB	Share
IMC Immuron lodges Form F-3 and ATM Prospectus with U.S. SEC
03/07/24		986.77KB	Share
IMC IMM-529 pre-IND FDA filing
02/07/24	PRICE SENSITIVE	367.2KB	Share
IMC Initial Director's Interest Notice JJ
05/06/24		168.43KB	Share
IMC Final Director's Interest Notice RA
05/06/24		176.44KB	Share
IMC Board Changes
31/05/24		215.04KB	Share
IMC Immuron CEO Steven Lydeamore to present at Peak Sky High
31/05/24		2.55MB	Share
IMC Notification of cessation of securities - IMC
24/05/24		12.8KB	Share
IMC Final Director's Interest Notice (SA)
03/05/24		179.96KB	Share
IMC Board Change
03/05/24		261.18KB	Share
IMC Change in substantial holding
30/04/24		643.75KB	Share
IMC Immuron CEO Steven Lydeamore to present at The Watchlist
23/04/24		1.83MB	Share
IMC Immuron to host Live Virtual Event
15/04/24		296.16KB	Share
IMC Immuron Travelan sales continued strong growth
10/04/24	PRICE SENSITIVE	315.78KB	Share
IMC Change in substantial holding
22/03/24		1.51MB	Share
IMC Notice under section 708A
14/03/24		179.38KB	Share
IMC Change of Director's Interest Notice (DP)
14/03/24		168.99KB	Share
IMC Application for quotation of securities - IMC
14/03/24		16.05KB	Share
IMC Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
14/03/24		1.29MB	Share
IMC Change in substantial holding
14/03/24		1.49MB	Share
IMC Travelan to progress to Phase 3 Clinical Trials in the US
07/03/24	PRICE SENSITIVE	408.71KB	Share
IMC Trading Halt
05/03/24	PRICE SENSITIVE	221.96KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.8¢		Change 0.000(0.00%)		Mkt cap ! $18.23M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	254876	6.8¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	20743	2

View Market Depth

No.	Vol.	Price($)
2	254876	0.068
2	10000	0.067
1	75000	0.066
2	87000	0.065
1	15858	0.063

Price($)	Vol.	No.
0.072	20743	2
0.073	22750	2
0.075	23346	2
0.076	15546	1
0.079	112658	2

Last trade - 16.21pm 05/09/2025 (20 minute delay)

IMC (ASX) Chart

Day chart unavailable

IMMURON LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Clean energy vehicles with hydrogen production and distribution all under one roof

Prospect Resources continues to advance Mumbezhi project

Leeuwin Metals set to unlock significant gold potential at Marda

Haranga Resources: From uranium in Senegal to gold in the US

Top Stories